- TWD3.17bn
- TWD2.65bn
- TWD983.55m
- 75
- 29
- 70
- 64
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,542 | 1,603 | 1,963 | 1,804 | 984 |
Cost of Revenue | |||||
Gross Profit | 382 | 393 | 561 | 530 | 309 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 1,490 | 1,530 | 1,752 | 1,599 | 961 |
Operating Profit | 52.2 | 73 | 211 | 204 | 22.3 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 71.7 | 108 | 343 | 283 | 84.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 48.5 | 79 | 265 | 213 | 79.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 49.3 | 79.2 | 265 | 214 | 78.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 49.3 | 79.2 | 265 | 214 | 78.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.602 | 0.959 | 3.18 | 2.58 | 0.953 |
Dividends per Share |